In a high-stakes hearing in Boston, Harvard University challenged the Trump administration's decision to pull about $2.5 billion in federal research grants, accusing officials of weaponizing funding under the pretext of combating antisemitism.
Harvard argues these grants fuel critical work – from cancer breakthroughs to emerging AI studies – that impacts patients and industries worldwide. 'The administration has given no consideration to patients, the public at large and the harm of all this research being cut off,' Harvard attorney Steven Lehotsky told U.S. District Judge Allison Burroughs.
On the other side, Justice Department lawyer Michael Velchik defended the cuts as a 'government priority not to send money to institutions that practice antisemitism,' adding, 'Harvard prioritized campus protesters over cancer research.'
Judge Burroughs, however, expressed skepticism. 'That's a major stumbling block for me,' she said, questioning whether policy disagreements could justify terminating federal grants.
The hearing – with no immediate ruling – marks a pivotal moment in the administration's broader push to leverage federal funding to reshape U.S. universities. As young global citizens, entrepreneurs and thought leaders watch closely, the outcome could redefine how research institutions navigate the political landscape and protect academic freedom worldwide.
Reference(s):
From Harvard case to tariffs, Trump's policies under scrutiny
cgtn.com
